Miist Therapeutics applies a physics-based approach to develop inhaled therapies that are faster acting and more effective than today's standard of care. The company's core technology is an inhaler that uses ultrasonic vibration to generate and deliver 2-micron aqueous drug particles to the peripheral lung, where they are instantly absorbed into the bloodstream.
Market
Inhaled therapies for common and debilitating conditions
Location
Alameda,
California,
USA
Coinvestors
1517 Fund, California Innovation Fund, Entrepreneur First, Freeflow Ventures, Refactor Capital